Pediatric heart allocation and transplantation in Eurotransplant
Standard
Pediatric heart allocation and transplantation in Eurotransplant. / Smits, Jacqueline M; Thul, Josef; De Pauw, Michel; Delmo Walter, Eva; Strelniece, Agita; Green, Dave; de Vries, Erwin; Rahmel, Axel; Bauer, Juergen; Laufer, Guenther; Hetzer, Roland; Reichenspurner, Hermann; Meiser, Bruno.
in: TRANSPL INT, Jahrgang 27, Nr. 9, 09.2014, S. 917-925.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Pediatric heart allocation and transplantation in Eurotransplant
AU - Smits, Jacqueline M
AU - Thul, Josef
AU - De Pauw, Michel
AU - Delmo Walter, Eva
AU - Strelniece, Agita
AU - Green, Dave
AU - de Vries, Erwin
AU - Rahmel, Axel
AU - Bauer, Juergen
AU - Laufer, Guenther
AU - Hetzer, Roland
AU - Reichenspurner, Hermann
AU - Meiser, Bruno
N1 - © 2014 Steunstichting ESOT.
PY - 2014/9
Y1 - 2014/9
N2 - Pediatric heart allocation in Eurotransplant (ET) has evolved over the past decades to better serve patients and improve utilization. Pediatric heart transplants (HT) account for 6% of the annual transplant volume in ET. Death rates on the pediatric heart transplant waiting list have decreased over the years, from 25% in 1997 to 18% in 2011. Within the first year after listing, 32% of all infants (<12 months), 20% of all children aged 1-10 years, and 15% of all children aged 11-15 years died without having received a heart transplant. Survival after transplantation improved over the years, and in almost a decade, the 1-year survival went from 83% to 89%, and the 3-year rates increased from 81% to 85%. Improved medical management of heart failure patients and the availability of mechanical support for children have significantly improved the prospects for children on the heart transplant waiting list.
AB - Pediatric heart allocation in Eurotransplant (ET) has evolved over the past decades to better serve patients and improve utilization. Pediatric heart transplants (HT) account for 6% of the annual transplant volume in ET. Death rates on the pediatric heart transplant waiting list have decreased over the years, from 25% in 1997 to 18% in 2011. Within the first year after listing, 32% of all infants (<12 months), 20% of all children aged 1-10 years, and 15% of all children aged 11-15 years died without having received a heart transplant. Survival after transplantation improved over the years, and in almost a decade, the 1-year survival went from 83% to 89%, and the 3-year rates increased from 81% to 85%. Improved medical management of heart failure patients and the availability of mechanical support for children have significantly improved the prospects for children on the heart transplant waiting list.
KW - Adolescent
KW - Age Determination by Skeleton
KW - Child
KW - Child, Preschool
KW - Europe
KW - Follow-Up Studies
KW - Health Policy
KW - Heart Diseases/mortality
KW - Heart Transplantation/mortality
KW - Heart-Assist Devices
KW - Humans
KW - Infant
KW - Kaplan-Meier Estimate
KW - Tissue Donors/supply & distribution
KW - Tissue and Organ Procurement/organization & administration
KW - Transplant Recipients/classification
KW - Treatment Outcome
KW - Waiting Lists/mortality
U2 - 10.1111/tri.12356
DO - 10.1111/tri.12356
M3 - SCORING: Journal article
C2 - 24853064
VL - 27
SP - 917
EP - 925
JO - TRANSPL INT
JF - TRANSPL INT
SN - 0934-0874
IS - 9
ER -